Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

• প্রধান লেখক: Charmi Patel (লেখক), Bruno Emond (লেখক), Marie-Hélène Lafeuille (লেখক), Aurélie Côté-Sergent (লেখক), Patrick Lefebvre (লেখক), Neeta Tandon (লেখক), Antoine C. El Khoury (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Purpose Reducing the dosing frequency of antipsychotics (APs) with long-acting injectables (LAIs) such as once-monthly paliperidone palmitate (PP1M) can improve adherence and clinical outcomes for schizophrenia patients. This US study compared physical and psychiatric comorbidity-related ou...